In the UK Daily Mail Christopher Gyngell, a research fellow in neuroethics at Oxford University, argues that we are morally obligated to use new DNA editing techniques like CRISPR, which can precisely edit the human genome, to cure genetic disease. He asserts that we must test the technique in human embryos with the hope of eradicating mutations that cause disease. He writes:
For nearly a decade, I have been trying to warn pro-lifers about the advent of genetically-modified, designer babies. Society's total blind acceptance of creating human life in the laboratory en masse with IVF has now brought us to this very precarious point. Scientists in China have taken left-over IVF embryos and tried to edit their DNA with a new promising gene-editing technique called CRISPR. It was not a success.
International surrogacy is often touted as a win-win situation. Western couples get a baby gestated for them at a low price, and the women in third world countries get more money than they would normally see in a lifetime.
It is very possible that the United States may follow the United Kingdom's lead and sanction the genetic engineering of future generations using technologies that create human embryos with the genetic material of three people. If Americans do not express our concern over these "mitochondrial replacement" (MR) procedures, which are very similar to the cloning technique that produced Dolly the Sheep, I fear MR will soon be offered by fertility clinics here.
At a time when more and more people are becoming wary of generically-modified foods in their diet, the United Kingdom is poised to begin creating genetically-modified children with the genetic material of three people, two women and one man; a genetic combination that could not occur naturally. And the way the UK goes, the United States may soon follow.
Logic purists will always call the appeal to the slippery slope a fallacy. You cannot argue against A just because it might lead to B.
Oh Huxley, what is your beloved country about to do?
In science fiction movies, it seems like it is easy to edit the genetics of a living organism. In reality, it is very, very difficult. A new technique in genetic engineering is creating quite a buzz in the genetics world because it allows researchers to do just that: edit the DNA of living cells.
There maybe new hope for the millions of patients worldwide that suffer from multiple sclerosis, better known as MS. MS is a debilitating and progressive disease where a patient's own immune system attacks the protective covering around the cells of the nervous system. This causes a wide range of varying and unpredictable symptoms including fatigue, decreased mobility, and visual disturbances.